Not provided
Not provided
Not provided
Not provided
Not provided
The recruitment proceeded much slower than expected. The planned number of patients could not be reached within the planned time.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Medical University Innsbruck | OTHER |
Not provided
Not provided
Not provided
Not provided
sensiTVT is a relatively new tape. The aim of this study is to analyze the objective and subjective outcome at one year follow-up.
Stress urinary incontinence (SUI) is defined as the involuntary leakage during physical activity and situations that result in an increase of abdominal pressure like sneezing, coughing or laughing and affects up to 25% of women. Currently there are a number of tapes on the market with GYNECARE TVT EXACT® (Tension free Vaginal Tape) and TVT- Obturator being one of the tapes with the highest subjective and objective cure rates and relatively low adverse events in women with normal sphincter pressure. Due to the recent FDA announcements several tapes have been withdrawn from the market and several new ones have been designed. Data from other tapes are available, however data especially from newer tapes is lacking.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sensiTVT | Device | The study is designed as a prospective single arm study. All women with an indication for suburethral tape placement for therapy of SUI and meeting the inclusion criteria will be offered study participation to record the objective outcome after one year. |
| Measure | Description | Time Frame |
|---|---|---|
| objective success of stress urinary incontinence | determined by a standardized cough stress test at 300 ml bladder, a negative cough stress test is a success. | one year |
| Measure | Description | Time Frame |
|---|---|---|
| Subjective success as determined using the Patient Global Impression of Improvement questionnaire. | defined as very much improved/much improved (1,2) on the Patient Global Impression of Improvement scale, while any other response (improved, same, worse, or much worse- 3-7) will be considered as failures. The Patient Global Impression of Improvement is a seven item scale validated for incontinence. |
Not provided
Inclusion criteria
Exclusion criteria:
Not provided
Not provided
women with stress urinary incontinence (SUI)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniela Gold (prev. Ulrich), MD PhD | Universitätsklinik für Frauenheilkunde und Geburtshilfe | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Obstetrics, Medical University Graz | Graz | 8045 | Austria |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 months+ one year |
| Peri- and postoperative complications | any surgical complications recorded | 3 months+ one year |
| Subjective incontinence cure rate using the Incontinence Outcome Questionnaire | The Incontinence Outcome Questionnaire was validated for postoperative assessment of quality of life after surgical treatment for stress urinary incontinence and has 27 items with lower scores indicating worse treatment outcome. The total score is calculated. | 3 months+ one year |
| quality of life using the Kings Health Questionnaire | The Kings Health Questionnaire was validated in women with stress urinary incontinence and assesses the impact of incontinence on quality of life. The eight subscales ("domains") scored between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst); lower scores indicate better QoL. Success in terms of the study is defined as 10 points improvement on the total Kings Health Questionnaire score. | 3 months+ one year |
| Subjective bother using the Patient Global Impression of Severity | Patient Global Impression of Severity The Patient Global Impression of Severity is a 7-item urinary symptom severity scale that is used to rate the severity of a specific condition -a single-state scale. The higher the number the worse the outcome of subjective bother of stress urinary incontinence. | 3 months+ one year |
| Patient satisfaction measured using a visual analogue scale | Patient satisfaction is defined as a score 8 to 10 on a 10-point visual analogue scale | 3 months+ one year |
| Sexual health using the Pelvic Organ Prolapse Incontinence Sexual Questionnaire | The Pelvic Organ Prolapse Incontinence Sexual Questionnaire is a 20 item questionnaire and is the primary measure used to assess sexual function in women with urinary incontinence and prolapse. Mean subscale scores are calculated by summing the valid responses to items in the subscale and then divided by the number of items with valid responses. The higher the subscores, the worse the outcome. | 3 months+ one year |
| Erosion rate | Erosion rate from the tape in the vagina or bladder | 3 months+ one year |
| Reoperation rate | Reoperation rate | 3 months+ one year |
| De novo urgency | De novo OAB- overactive bladder as determined by clinical history taking | 3 months+ one year |
| De novo pain in the operated region | De novo pain in the operated region as determined by clinical history taking | 3 months+ one year |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |